Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mylan NV Ord Shs (MYL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Glaxo Presents Encouraging Data on Endometrial Cancer Drug

Glaxo (GSK) presents encouraging data from phase I/II study on endometrial cancer drug, dostarlimab.

MYL : 29.25 (+1.88%)
MRK : 82.95 (+1.06%)
GSK : 41.24 (+1.05%)
PFE : 42.35 (+0.43%)
After Yesterday's Rally of 1.63% Shares Could Potentially Pullback

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $27.93 to a high of $28.74. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $28.55...

MYL : 29.25 (+1.88%)
Watch for Mylan Nv to Potentially Pullback After Gaining 1.63% Yesterday

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $27.93 to a high of $28.74. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $28.55...

MYL : 29.25 (+1.88%)
Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter

Mylan Institutional LLC is conducting a voluntary nationwide recall of two lots (see table below) of Levoleucovorin Injection, 250 mg/25 mL tothe consumer/user level. The lots were manufactured by Alidac...

MYL : 29.25 (+1.88%)
Mapi Pharma Receives Government of Israel Funding for the Establishment of a Finished Dosage Form Facility for the Manufacturing of GA Depot Pharmaceuticals

Mapi Pharma Ltd., a fully integrated, clinical, late stage biopharmaceutical company, announced today that it has received complementary funding from the Israeli Ministry of the Economy to build a new...

MYL : 29.25 (+1.88%)
MAPI : N/A (unch)
Mylan Nv is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (MYL , OMER , PCRX , HZNP , LCI )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

MYL : 29.25 (+1.88%)
PCRX : 39.75 (+0.13%)
OMER : 17.72 (+0.91%)
Insys Plunges on Auditor's Concern About Insufficient Funds

Insys Therapeutics' (INSY) shares plunge after its auditor raises concerns related to insufficiency of funds to continue operations.

MYL : 29.25 (+1.88%)
ENDP : 8.76 (+0.34%)
INSY : 4.81 (+1.69%)
TEVA : 17.08 (+1.30%)
Mylan Nv Set to Possibly Pullback After Yesterday's Rally of 1.33%

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $27.35 to a high of $27.59. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $27.32...

MYL : 29.25 (+1.88%)
SBP, Mylan Present Keys to Hurricane Maria Survivor in Welcome Home Party -- Courtesy of $1M Pledge from the Mylan Charitable Foundation

A small crowd of SBP staff, AmeriCorps members, Puerto Rico Central Office of Recovery and Reconstruction's Omar J. Marrero, Esq and volunteers from global pharmaceutical company Mylan (NASDAQ: MYL) gathered...

MYL : 29.25 (+1.88%)
New Research: Key Drivers of Growth for Toll Brothers, Mylan N.V, Eldorado Resorts, Sinclair Broadcast Group, Eldorado Gold, and Pegasystems -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Toll Brothers Inc. (NYSE:TOL),...

TOL : 35.74 (+2.47%)
MYL : 29.25 (+1.88%)
SBGI : 38.60 (+3.60%)
PEGA : 65.33 (+1.18%)
EGO : 4.55 (-3.40%)
ERI : 50.07 (+3.90%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (OMER , MYL , COLL , TXMD , BMY )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

MYL : 29.25 (+1.88%)
COLL : 17.00 (-3.41%)
OMER : 17.72 (+0.91%)
Mylan to Present at Raymond James 40th Annual Institutional Investors Conference

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that CFO Ken Parks will present at the Raymond James 40th Annual Institutional Investors Conference in Orlando, Fla., on Tuesday,...

MYL : 29.25 (+1.88%)
Implied Volatility Surging for Mylan (MYL) Stock Options

Investors need to pay close attention to Mylan (MYL) stock based on the movements in the options market lately.

MYL : 29.25 (+1.88%)
Weight Watchers plunges, Best Buy and Campbell Soup jump

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Wednesday:

VSM : 50.17 (+1.66%)
MYL : 29.25 (+1.88%)
DF : 3.10 (+3.33%)
CPB : 37.86 (+4.24%)
WTW : 19.80 (+1.54%)
EOG : 96.87 (+1.02%)
PANW : 249.79 (+1.61%)
MKKGY : 22.8000 (-0.52%)
Theravance (TBPH) Q4 Loss Narrows, Revenues Beat Estimates

Theravance Biopharma (TBPH) incurs narrower-than-expected loss in Q4. The top line surpasses estimates.

TBPH : 24.49 (+1.20%)
MYL : 29.25 (+1.88%)
JNJ : 138.10 (+0.59%)
GSK : 41.24 (+1.05%)
Mylan Nv Falls 11.37% on Heavy Volume: Watch For Potential Rebound

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $26.20 to a high of $27.14. Yesterday, the shares fell 11.4%, which took the trading range below the 3-day low of $30.55 on...

MYL : 29.25 (+1.88%)
SmarTrend Watching for Potential Rebound in Shares of Mylan Nv After 11.37% Loss

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $26.20 to a high of $27.14. Yesterday, the shares fell 11.4%, which took the trading range below the 3-day low of $30.55 on...

MYL : 29.25 (+1.88%)
Mylan (MYL) Q4 Earnings & Revenues Miss Estimates, Stock Down

Mylan (MYL) Q4 earnings and sales miss estimates due to persistent challenges in the North America segment. The guidance for 2019 was weak as well.

MYL : 29.25 (+1.88%)
TEVA : 17.08 (+1.30%)
RHHBY : 34.1200 (+0.09%)
GSK : 41.24 (+1.05%)
Mylan Reports Fourth Quarter and Full Year 2018 Results and Provides 2019 Guidance

Mylan N.V. (NASDAQ: MYL) today announced its financial results for the fourth quarter and the year ended December 31, 2018 and provided 2019 guidance.

MYL : 29.25 (+1.88%)
Momenta (MNTA) Q4 Loss Narrower Than Expected, Revenues Beat

Momenta (MNTA) reported a narrower loss in Q4, while sales came ahead of expectations.

MYL : 29.25 (+1.88%)
MNTA : 14.10 (+2.40%)
ABBV : 81.24 (+1.01%)
TEVA : 17.08 (+1.30%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ unch
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar